BRCA1 and PALB2 proteins suppress tumor formation by promoting homologous recombination when DNA damage has occurred. Mutations in BRCA1 and PALB2 are associated with a higher prevalence of breast and ovarian cancers. Phosphorylation of BRCA1 and PALB2 occurs upon DNA damage and is vital for maintaining genomic integrity. The molecular mechanism of how phosphorylation directs the activation of these proteins is unknown. It is established that phosphorylation of BRCA1 and PALB2 occurs in or near the coiled-coil regions of both proteins. The proteins use this domain to heterodimerize, so we hypothesize that the phosphorylation events could promote efficient BRCA1/PALB2 interactions. Our study aims to determine the effect of phosphorylation on the BRCA1/PALB2 binding affinity. The serine and threonine residues that are phosphorylated on BRCA1 or PALB2 were mutated to a glutamic acid to mimic phosphorylation. Glutamic acid carries a negative charge and thus mimics the negative charge added to the protein upon phosphorylation. We overexpressed and purified the protein using a bacterial expression system and measured their heterodimerization affinity with isothermal titration calorimetry (ITC). We will share ITC data suggesting phosphorylation of PALB2 does not affect its binding affinity to BRCA1. The phosophomimicking mutations in BRCA1 have also been generated, both individually and in tandem, and we will share results from these binding studies that are ongoing and hypotheses generated from our results regarding phosphorylation as an activation switch to control BRCA1/PALB2 interactions.

The Identification of Novel Genes Related to Iron Acquisition in Bacillus Anthracis Sterne

Jessica Guilhas, Kyle Gallegos, Julio Manceras, Mariah Green, Jacob Malmquist, Shauna M. McGillivray

Bacillus anthracis, the causative agent of anthrax, is a spore-forming, gram-positive bacterium. Its virulence mechanisms are of interest due to its potential use as a biological weapon and high lethality. For B. anthracis to survive and reproduce in a host, it must evade the host's immune response and acquire nutrients. One important nutrient B. anthracis must acquire is iron. Iron is a limiting nutrient in the host because it is usually found sequestered to hemoglobin or bound to host proteins such as transferrin. To acquire iron, pathogens must strip it from the host proteins. To find genes important for iron acquisition from hemoglobin, we screened genetic mutants created through transposon mutagenesis. Media was chelated to remove all divalent cations, including iron, and then hemoglobin was added as the sole iron source. The mutants that were unable to grow were chosen to be tested in a larger volume hemoglobin assay. We confirmed the phenotype of several mutants using this larger volume assay and we are working to confirm the site of transposon disruption via PCR. The mutants thus identified include a mutation in a dUTPase gene and an L-aspartate oxidase gene, neither of which has been previously linked to iron acquisition from hemoglobin. Future directions include making independent mutations and/or complement the disrupted genes to confirm the gene disruption is linked to loss of iron acquisition from hemoglobin. This study allows for a further understanding of how B. anthracis acquires iron and sheds new light on potentially novel virulence mechanisms.

Alzheimer’s disease (AD) is a neurodegenerative disease characterized by the formation of amyloid beta (Aβ) plaques in the brain and is the seventh leading cause of death in the United States. Chronic inflammation and oxidative stress associated with AD leads to neuronal cell death. A cellular protective mechanism against oxidative stress involves the Nuclear factor erythroid 2-related factor (Nrf2) pathway. Nrf2 is responsive to the reactive oxygen species (ROS) produced when the cell is under oxidative stress, leading to its translocation into the nucleus where it activates transcription of genes that produce antioxidant enzymes like heme oxygenase-1 (HO-1). To study this pathway in neurons, our lab chose to use the mouse hippocampal HT-22 neuronal cell line. Our previous attempts to grow these cells in culture proved difficult, leading us to hypothesize that providing a growth-enhancing surface of collagen would provide a more stable surface in which to propagate these cells. Here we show that HT-22 cells grown on rat tail collagen provide a model system to investigate the Nrf2 pathway. We also demonstrate that HT-22 cells are viable on tissue culture plastics without the need for collagen.

Exploring EncT Efflux Pump Functionality and their Role in Lipid Signaling
Gabby Linares, Sawyer Diaz, Natalia Castro-Lopez, Floyd Wormley Jr.
Department of Biology, Texas Christian University

Cryptococcus neoformans, a fungal pathogen mainly affecting immunocompromised individuals, has sparked interest in lipid signaling research due to its role in pathogenesis. Eicosanoids, derived from fatty acids, are crucial in virulence and immune modulation; with C. neoformans lacking human enzyme homologs for eicosanoids biosynthesis, we want to identify the enzymes involved in the biosynthesis of cryptococcal eicosanoids and test their potential as antifungal targets. This project is focused on the EncT gene, encoding an efflux pump, which we observed to be upregulated in response to lipid precursors. Using CRISPR technology, we produced an EncT knockout (KO) strain and the corresponding reconstituted strain, aiming to discern shifts in virulence factors like melanin production, capsule formation, and urea production, among others, comparing the knockout, wild-type, and reconstituted strains and, subsequently, employing a mouse model of pulmonary cryptococcosis to delve deeper into virulence dynamics. Our initial results show early production of melanin EncT KO compared to the WT strain and no changes in the capsule formation or growth at 37°C.

Fabian Lopez1,2, Cameron Bowers3, Giri Akkaraju1,3, Texas Christian University1, Department of Chemistry and Biochemistry2, Department of Biology3

Microglial cells are resident immune cells in the human brain that mediate the inflammatory response. The molecular hallmarks of Alzheimer’s Disease are neurofibrillary tangles and amyloid-B protein aggregates. In response to this buildup of these proteins, microglial cells release pro-inflammatory cytokines, such as TNF-alpha to recruit other microglia to this site of injury. However, when the microglia are unable to remove the waste, there is then a continuous cycle of cytokine secretion and microglia recruitment that leads to chronic inflammation. The NF-kB pathway is activated when molecules of bacterial cell walls, such as LPS, bind to toll-like receptor 4 (TLR4) in infected cells. This results in the translocation of NF-kB to the nucleus where it induces the expression of the TNF-alpha gene. In order to attenuate this response, our collaborators at P2D Biosciences and the Lab of Dr. Kayla Green at TCU have designed anti-inflammatory drugs. BV-2 cells are microglial mouse cells that are used as a model to test the efficacy of these drugs. The cytotoxicity of these drugs was first measured using an MTT assay to ensure that any observed reductions in secretions of cytokines such as TNF-alpha can be attributed to inhibition of inflammatory signaling pathways by the drug. An Enzyme-Linked Immunosorbent Assay (ELISA) was utilized to quantify and compare the levels of TNF-alpha in control and drug treated groups. The preliminary results suggest that Dr. Green’s drug, PK60, leads to a reduction in the levels of TNF-alpha secreted by BV-2 cells. This work serves as basis for employing techniques to investigate how upstream messengers of the NF-kB pathway are affected by PK60 to identify its mechanism of action.